North America Spirometer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Handheld Spirometers, Table-top Spirometers, and Desktop Spirometers), Technology (Volume, Flow, and Peak Flow), and Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Others)
The spirometer market in North America is expected to grow from US$ 392.53 million in 2022 to US$ 762.94 million by 2028. It is estimated to grow at a CAGR of 11.7% from 2022 to 2028.
The higher prevalence of respiratory disorders is related to the decrease in the size of the upper airway lumen in the aging population. Lung diseases are among the most common medical conditions. Further, smoking, genetic factors, and infections are common factors responsible for respiratory diseases. Various medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer, are significant public health burdens. According to the US Department of Health and Human Services, 25 million people in the US had asthma in 2019, known to be the most common respiratory disease. With the increasing prevalence of smoking in developing countries and the aging population in high-income countries, COPD incidence is projected to rise over the next forty years. Patients suffering from respiratory disorders commonly experience difficulty in breathing.
Further, early detection and diagnosis can help treat respiratory disease patients. In such cases, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, the market is witnessing positive growth with the increasing incidence of such respiratory diseases.
North America Spirometer Market Revenue and Forecast to 2028 (US$ Million)
North America Spirometer Market Segmentation
The North America spirometer market is segmented by type, technology, application, and country. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment dominated the market in 2022. By technology, the market is segmented into volume, flow, and peak flow. The flow segment dominated the market in 2022. By application, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. The chronic obstructive pulmonary disease segment dominated the market in 2022. Based on country, the market is segmented into the US, Canada, and Mexico. Further, the US dominated the market in 2022.
A few key players dominating the North America spirometer market are Baxter International Inc.; Benson Medical Instruments Co.; COSMED Srl; Depisteo LLC.; Henry Schein, Inc.; ICU Medical Inc.; Jones Medical Instrument Company; NUVOAIR US, INC. (NUVOAIR AB); Teleflex Incorporated; and VYAIRE MEDICAL, INC.
Reasons to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Spirometer Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America Spirometer Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Spirometer Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook